MXC Capital Limited Now holds 29.98% of Adept4 Shares

MXC Capital Limited ORD NPV
[shareaholic app="share_buttons" id_name="post_below_content"]

MXC Capital Limited (LON: MXCP) announced today that on 16 November 2018 it bought 11.3 million ordinary shares of 1 penny each in the capital of Adept4 plc (LON: AD4), at a price of 1.1 pence per AD4 Share.

Following this purchase, MXC holds 68,066,275 AD4 Shares, representing 29.98% of its issued share capital.

AD4 delivers IT as a service to small and medium sized businesses across the UK and is listed on the AIM market of the London Stock Exchange. Further details about AD4 (including latest financial reports) are available at www.adept4.co.uk.

MXC Capital Limited is a specialist adviser and investor with a track record of investing in and advising companies in the TMT sector. We bring together a deep knowledge of technology, first-hand experience of managing companies in the sector, an ability to make meaningful investments and a highly experienced corporate advisory team in support, all of which we combine to grow shareholder value.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Argent BioPharma Ltd, formerly MGC Pharmaceuticals Limited, is a pioneering drug discovery company in the biopharmaceutical sector. Learn about their recent name change and impactful advancements in drug development.

      Search

      Search